Agreed THC completely different biz to us.
I'd assume dental biz is worth around 10-20M MC as it was trading as such before the company moved into medicinal cannabis.
For oils side of the biz I'd compare to AGH in terms of revs and patient numbers. They are also partnered w/ Cannvalate for distribution. AGH currently at 90M MC and is still very far off its ATH.
Then the novel IP trials side which is the real company maker, BOT was the closest thing we had to a leading peer before they had their 2 botched trials. BOT was trading at over 200M MC at their highs for months. They did so after I think achieving 2 successful trial results, one in acne and one in a superbug killer. Both iirc were Phase 1B.
IHL trading in a very uncertain state atm because we haven't proved anything so far, derisking hasnt happened yet.
INCANNEX was only formed mid last year, and from Oct to December we sourced 1K patients. First revs only came end of last quarter, so to the market we are still fairly unproven.
IHL needing to execute its trials and continue to grow the oils biz which it is currently doing. Continued growth in oils sales alone will raise our MC from these levels IMO, but to see another epic run the only catalyst that can achieve this is trial success. That's why we are all here.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-252
-
- There are more pages in this discussion • 19,648 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online